Average Co-Inventor Count = 13.68
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Celgene Corporation (14 from 550 patents)
2. Signal Pharmaceuticals, Inc. (4 from 169 patents)
3. Bristol-myers Squibb Compnay (1 from 3,685 patents)
4. Biotheryx, Inc. (1 from 36 patents)
19 patents:
1. 12419962 - Quinazolines, pharmaceutical compositions, and therapeutic applications
2. 12404239 - Modulators of BCL6 as ligand directed degraders
3. 12404241 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
4. 12227490 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
5. 12103920 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
6. 12029738 - Antiproliferative compounds and methods of use thereof
7. 11873283 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
8. 11739075 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
9. 11634407 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
10. 11560371 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
11. 11325889 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
12. 11185543 - Antiproliferative compounds and methods of use thereof
13. 11149007 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
14. 10675281 - Antiproliferative compounds and methods of use thereof
15. 10357489 - Antiproliferative compounds and methods of use thereof